Bcl-xL
BCL-XL (B-cell lymphoma-extra large), an anti-apoptotic member of the BCL-2 family proteins, is prominently found in the inner membrane of mitochondria and characterized by containing all four BCL-2 homology (BH) domains (BH1 to BH4). A hydrophobic cleft (the BH3-binding groove) formed by apposition of the BH1, BH2 and BH3 domains has been identified in the molecular surface of BCL-XL, through which it interacts with pro-apoptotic BCL-2 proteins, Bax and Bak, to inhibit apoptosis. Moreover, BCL-XL also exhibits anti-autophagy abilities to avoid autophagic cell death by binding to protein Beclin 1, which is required to initiate the formation of autophagasome in autophagy.
Produkte für Bcl-xL
- Bestell-Nr. Artikelname Informationen
-
GC17512
A-1155463
A-1155463 ist ein hochwirksamer und selektiver BCL-XL-Inhibitor mit einem EC50-Wert von 70 nM in Molt-4-Zellen.
-
GC17513
A-1331852
A-1331852 ist ein oral verfÜgbarer selektiver BCL-XL-Inhibitor mit einem Ki von weniger als 10 pM.
-
GC17234
ABT-737
ABT 737, ABT737
An inhibitor of anti-apoptotic Bcl-2 proteins -
GC12139
Gambogic Acid
GA, β-Guttiferin
Gambogic Acid A cell-permeable caspase activator and apoptosis inducer commonly used in studies of breast, lung, and liver cancers. -
GC11510
HA14-1
A Bcl-2 inhibitor
-
GC12649
TW-37
An inhibitor of the Bcl-2 family proteins
-
GC11921
WEHI-539
WEHI539,WEHI 539
A selective Bcl-xL inhibitor -
GC13317
WEHI-539 hydrochloride
WEHI-539 Hydrochlorid ist ein selektiver Inhibitor von Bcl-XL mit einem IC50 von 1,1 nM.